NGeneBio Co., Ltd. 354200.KQ Stock
NGeneBio Co., Ltd. Price Chart
NGeneBio Co., Ltd. 354200.KQ Financial and Trading Overview
NGeneBio Co., Ltd. stock price | 3020 KRW |
Previous Close | 6940 KRW |
Open | 7000 KRW |
Bid | 6900 KRW x N/A |
Ask | 7040 KRW x N/A |
Day's Range | 6870 - 7000 KRW |
52 Week Range | 6270 - 11850 KRW |
Volume | 37.56K KRW |
Avg. Volume | 72.67K KRW |
Market Cap | N/A |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
354200.KQ Valuation Measures
Enterprise Value | 82.24B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
NGeneBio Co., Ltd. Stock Price History
Beta (5Y Monthly) | N/A |
52-Week Change | -16.38% |
S&P500 52-Week Change | 20.43% |
52 Week High | 11850 KRW |
52 Week Low | 6270 KRW |
50-Day Moving Average | 7481.6 KRW |
200-Day Moving Average | 8331.75 KRW |
354200.KQ Share Statistics
Avg. Volume (3 month) | 72.67K KRW |
Avg. Daily Volume (10-Days) | 29.51K KRW |
Shares Outstanding | N/A |
Float | N/A |
Short Ratio | N/A |
% Held by Insiders | 31.06% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | N/A |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | N/A |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | N/A |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | 51.20% |
Gross Profit (ttm) | N/A |
EBITDA | N/A |
Net Income Avi to Common (ttm) | N/A |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 37.73B KRW |
Total Cash Per Share (mrq) | 3017.47 KRW |
Total Debt (mrq) | 10.88B KRW |
Total Debt/Equity (mrq) | 36.43 KRW |
Current Ratio (mrq) | N/A |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | N/A |
Levered Free Cash Flow (ttm) | N/A |
Profile of NGeneBio Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | #303-307, 904ho, 288, Digital-ro |
ZIP | 08390 |
Phone | 82 2 867 9798 |
Website | https://ngenebio.com |
Industry | |
Sector(s) | |
Full Time Employees | N/A |
NGeneBio Co., Ltd. develops in vitro diagnostics companion diagnostics products and bioinformatics software. It offers BRCAaccuTest and BRCAaccuTest PLUS are reagent kits for breast and ovarian cancer, and hereditary breast and ovarian cancer syndrome; HEMEaccuTest, a clinical NGS kit for hematological malignancies, such as acute myeloid leukemia, acute lymphoid leukemia, myelodysplastic/myeloproliferative neoplasm, multiple myeloma, and lymphoma; SOLIDaccuTest, a genetic variants screening for solid tumors; HLAaccuTest, an in vitro diagnostic medical device for human leukocyte antigen typing; and OncoaccuPanel, a solid tumor oncology next generation sequencing test. The company also provides NGeneAnalySys, a software for analysis of the genetic testing data; and EasyHLAanalyzer, which offers the HLA typing identifing human leukocyte antigen for histocompatibility antigens using data from NGS. In addition, it offers IDaccuTest, a short tandem repeat test for family relationship testing, identity testing, forensics, and chimerism analysis; and NGenePlex nCoV qRT-PCR Kit, a reagent of real-time reverse transcription-polymerase chain reaction assay intended for the qualitatively detecting nucleic acid of SARS-CoV-2 from patients infected or suspected of COVID-19. The company was founded in 2015 and is headquartered in Seoul, South Korea.
Q&A For NGeneBio Co., Ltd. Stock
What is a current 354200.KQ stock price?
NGeneBio Co., Ltd. 354200.KQ stock price today per share is 3020 KRW.
How to purchase NGeneBio Co., Ltd. stock?
You can buy 354200.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NGeneBio Co., Ltd.?
The stock symbol or ticker of NGeneBio Co., Ltd. is 354200.KQ.
How many shares does NGeneBio Co., Ltd. have in circulation?
The max supply of NGeneBio Co., Ltd. shares is 12.89M.
What is NGeneBio Co., Ltd. Price to Earnings Ratio (PE Ratio)?
NGeneBio Co., Ltd. PE Ratio is now.
What was NGeneBio Co., Ltd. earnings per share over the trailing 12 months (TTM)?
NGeneBio Co., Ltd. EPS is 0 KRW over the trailing 12 months.
NGeneBio Co., Ltd. 354200.KQ included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Kosdaq Other Services Index KQ16 | 3995.32 KRW 3.02 USD |
+0.96
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}